We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Sarah Whelan, PhD

Sarah Whelan, PhD profile page

Science Writer

 at Technology Networks


Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.


Education


University of Kent  

University of Leicester  


Areas of Expertise



Got a Question for Sarah Whelan, PhD?


Get in touch using the contact form linked here and we’ll get back to you shortly.



Published Content
Total: 304
A digital illustration of a brain lit up in multiple colors.
News

Largest-Ever Genetic Study on Epilepsy Uncovers Potential Therapeutic Paths

One of the largest and most diverse studies to date on genetic factors related to epilepsy has revealed potential new treatment targets.
A glowing award icon.
Industry Insight

Innovation Award Winner Announced at ELRIG Drug Discovery 2024

Technology Networks had the pleasure of speaking with the ELRIG Innovation Award Winner Constructive Bio’s CEO, Dr. Ola Wlodek, to discuss its award-winning innovations and learn more about its mission.
A digital render of a brain showing connections between different areas.
Article

The Evolving Treatment Landscape for Alzheimer’s

We spoke to Andrew Doig, professor of biochemistry at the University of Manchester, to find out more about the evolving landscape of Alzheimer's treatments.
A person in a lab coat holding a representation of a medical AI.
News

AI Model May Help Guide Cancer Diagnosis and Treatment

Researchers have developed an AI model that can perform an array of diagnostic tasks for multiple forms of cancer, improving upon existing AI systems.
A flat-lay of high-fat foods.
News

Ketogenic Diet Improves Pancreatic Cancer Therapy in Animal Model

A study investigating the effects of fasting and the ketogenic diet has revealed a new vulnerability of pancreatic tumors to a cancer drug currently in clinical trials.
Dr. Cuella Martin standing in front of a blossoming tree.
Article

LGBTQIA+ Representation and Creating Inclusive Environments: A Q&A With Dr. Raquel Cuella Martin

In this interview, we spoke to Dr. Raquel Cuella Martin to learn about her research, her experiences working as an LGBTQIA+ researcher in STEMM and her advice for others beginning a STEMM career.
Pills seen through a magnifying glass.
News

New Technique May Reveal Repurposing Potential for Existing Drugs

A new technique may help reveal unknown benefits of existing drugs, according to a new study. The new approach, called decryptE, could help identify new applications for already approved drugs and take steps toward precision medicine.
The outline of a face with stars and a galaxy.
News

MDMA-Assisted PTSD Therapy Rejected by FDA

The US Food and Drug Administration (FDA) has rejected the use of MDMA-assisted therapy for post-traumatic stress disorder (PTSD), according to an announcement from the therapy’s drugmaker, Lykos Therapeutics.
Several neurons connected to each other.
News

New Compound Restores Memory in Alzheimer’s Mouse Model

A new molecule developed by University of California Los Angeles (UCLA) researchers can restore lost cognitive functions in mice with symptoms of Alzheimer's disease, according to a new study published in PNAS.
Neurons connecting with each other.
News

Drug Candidate Shows Promise in Reversing MS Nerve Damage in Mouse Model

Researchers have developed a drug that shows promise in animal models of multiple sclerosis (MS). If successful in humans, the drug could help to replace the protective insulation around nerve cells lost because of the disease.
Advertisement